C4 Therapeutics (CCCC) Asset Utilization Ratio: 2020-2025
Historic Asset Utilization Ratio for C4 Therapeutics (CCCC) over the last 5 years, with Sep 2025 value amounting to 0.11.
- C4 Therapeutics' Asset Utilization Ratio rose 20.48% to 0.11 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11, marking a year-over-year increase of 20.48%. This contributed to the annual value of 0.10 for FY2024, which is 90.62% up from last year.
- According to the latest figures from Q3 2025, C4 Therapeutics' Asset Utilization Ratio is 0.11, which was down 3.61% from 0.11 recorded in Q2 2025.
- In the past 5 years, C4 Therapeutics' Asset Utilization Ratio registered a high of 0.12 during Q1 2025, and its lowest value of 0.04 during Q2 2023.
- Its 3-year average for Asset Utilization Ratio is 0.08, with a median of 0.08 in 2024.
- Its Asset Utilization Ratio has fluctuated over the past 5 years, first plummeted by 58.14% in 2023, then skyrocketed by 129.92% in 2025.
- Quarterly analysis of 5 years shows C4 Therapeutics' Asset Utilization Ratio stood at 0.09 in 2021, then fell by 22.77% to 0.07 in 2022, then fell by 16.05% to 0.06 in 2023, then skyrocketed by 67.61% to 0.10 in 2024, then increased by 20.48% to 0.11 in 2025.
- Its Asset Utilization Ratio was 0.11 in Q3 2025, compared to 0.11 in Q2 2025 and 0.12 in Q1 2025.